TrialOpen forum infectious diseases2025

Dolutegravir/Abacavir/Lamivudine in Acute HIV-1 Results in Rapid Suppression and Restoration of CD4 T-cell Subsets Without Accelerated Decay of Latent HIV-1.

Cynthia L Gay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.